首页 > 最新文献

Northern Clinics of Istanbul最新文献

英文 中文
Endovascular closure of an arterivenous graft for dialysis-associated steal syndrome of lower extremity. 血管内闭合动静脉移植物治疗下肢透析相关窃血综合征。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2020.11298
Sebnem Albeyoglu, Osman Eren Karpuzoglu, Sevinc Bayer Erdogan, Murat Bastopcu, Arif Yasin Cakmak, Emine Dudu Can, Halit Er

Steal syndrome causing limb ischemia is a rare but important complication of arteriovenous fistulas. When surgical or endovascular means to resolve ischemia are inconclusive, closure of the fistula becomes required. Our case presented with lower extremity ischemia resulting from an arteriovenous fistula graft. We present the successful endovascular closure of the lower extremity graft using the Amplatzer Vascular Plug.

偷盗综合征引起肢体缺血是动静脉瘘的一种罕见但重要的并发症。当手术或血管内方法解决缺血不确定时,就需要关闭瘘管。我们的病例提出了下肢缺血造成的动静脉瘘移植物。我们介绍了使用Amplatzer血管塞对下肢移植物进行血管内闭合的成功案例。
{"title":"Endovascular closure of an arterivenous graft for dialysis-associated steal syndrome of lower extremity.","authors":"Sebnem Albeyoglu,&nbsp;Osman Eren Karpuzoglu,&nbsp;Sevinc Bayer Erdogan,&nbsp;Murat Bastopcu,&nbsp;Arif Yasin Cakmak,&nbsp;Emine Dudu Can,&nbsp;Halit Er","doi":"10.14744/nci.2020.11298","DOIUrl":"https://doi.org/10.14744/nci.2020.11298","url":null,"abstract":"<p><p>Steal syndrome causing limb ischemia is a rare but important complication of arteriovenous fistulas. When surgical or endovascular means to resolve ischemia are inconclusive, closure of the fistula becomes required. Our case presented with lower extremity ischemia resulting from an arteriovenous fistula graft. We present the successful endovascular closure of the lower extremity graft using the Amplatzer Vascular Plug.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"530-532"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/f8/NCI-9-530.PMC9677045.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis. 在骨髓炎大鼠模型中,利福昔明间隔剂的应用并不优于局部替柯planin治疗。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.04935
Mucahid Osman Yucel, Yalcin Turhan, Mehmet Arican, Zekeriya Okan Karaduman, Sonmez Saglam, Yildiray Tekce, Mehmet Gamsizkan

Objective: Acute and chronic osteomyelitis generally require long-term antibiotic therapy and surgical debridement. Implant-associated osteomyelitis, particularly from methicillin-resistant Staphylococcus aureus (MRSA) strains, is difficult to treat. Rifaximin is an antibiotic derived from rifamycin which may be effective in the treatment of osteomyelitis in terms of its wide spectrum of action and pharmacological properties. The aim of this experimental study was to investigate the local efficacy of rifaximin in rat models with MRSA and implant associated osteomyelitis.

Methods: This study was carried out with 40 adult Wistar albino rats. The rats were randomly divided into 4 equal groups with 10 rats in each. An implant related MRSA osteomyelitis was created in the right tibia metaphysis of each rat by Norden's experimental osteomyelitis model. After 4 weeks, the implants of each tibia were removed and debridement was applied. Group 1 was designed as control group and no other treatment was applied other than debridement. Bone cement without any antibiotic was applied to Group 2, bone cement with teicoplanin was applied to Group 3 and bone cement with rifaximin was applied to Group 4. After 4 weeks from the second surgery, euthanasia was performed to the rats and the clinical, histopathological and microbiological results were compared.

Results: There was no statistically significant difference between the groups in clinical scoring. A statistically significant difference was found between the histopathological scores of Group 1 and Group 2 and the histopathological scores of Groups 3 and 4; the histopathological scores of Group 1 and Group 2 were found to be higher than Group 3 and Group 4. When the pre-and post-treatment colony numbers were compared, although there was a statistically significant difference between Group 3 and Group 2, no statistically significant difference was found between Group 4 and Group 1 results.

Conclusion: In spite of its wide spectrum, the local efficacy of rifaximin in the treatment of osteomyelitis could not be demonstrated. This study shows the ability to shed light on some future comprehensive studies with the inclusion of infection markers.

目的:急性和慢性骨髓炎通常需要长期抗生素治疗和手术清创。种植体相关性骨髓炎,特别是耐甲氧西林金黄色葡萄球菌(MRSA)菌株引起的骨髓炎很难治疗。利福昔明是利福霉素衍生的一种抗生素,由于其广泛的作用谱和药理特性,可能有效治疗骨髓炎。本实验研究的目的是探讨利福昔明对MRSA和种植体相关性骨髓炎大鼠模型的局部疗效。方法:以40只成年Wistar白化大鼠为实验对象。将大鼠随机分为4组,每组10只。采用Norden的实验性骨髓炎模型,在每只大鼠右侧胫骨干骺端制造与植入物相关的MRSA骨髓炎。4周后,取出胫骨内种植体,进行清创。第一组为对照组,除清创外不进行其他治疗。2组采用不含抗生素的骨水泥,3组采用替柯planin骨水泥,4组采用利福昔明骨水泥。第二次手术后4周,对大鼠实施安乐死,比较临床、组织病理学和微生物学结果。结果:两组患者临床评分差异无统计学意义。1、2组的组织病理学评分与3、4组的组织病理学评分比较,差异有统计学意义;组1和组2的组织病理学评分高于组3和组4。比较治疗前后菌落数,虽然3组与2组有统计学差异,但4组与1组结果无统计学差异。结论:利福昔明治疗骨髓炎的局部疗效虽具有广谱性,但尚不能证实。这项研究表明,有能力揭示一些未来的综合研究,包括感染标志物。
{"title":"Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis.","authors":"Mucahid Osman Yucel,&nbsp;Yalcin Turhan,&nbsp;Mehmet Arican,&nbsp;Zekeriya Okan Karaduman,&nbsp;Sonmez Saglam,&nbsp;Yildiray Tekce,&nbsp;Mehmet Gamsizkan","doi":"10.14744/nci.2022.04935","DOIUrl":"https://doi.org/10.14744/nci.2022.04935","url":null,"abstract":"<p><strong>Objective: </strong>Acute and chronic osteomyelitis generally require long-term antibiotic therapy and surgical debridement. Implant-associated osteomyelitis, particularly from methicillin-resistant Staphylococcus aureus (MRSA) strains, is difficult to treat. Rifaximin is an antibiotic derived from rifamycin which may be effective in the treatment of osteomyelitis in terms of its wide spectrum of action and pharmacological properties. The aim of this experimental study was to investigate the local efficacy of rifaximin in rat models with MRSA and implant associated osteomyelitis.</p><p><strong>Methods: </strong>This study was carried out with 40 adult Wistar albino rats. The rats were randomly divided into 4 equal groups with 10 rats in each. An implant related MRSA osteomyelitis was created in the right tibia metaphysis of each rat by Norden's experimental osteomyelitis model. After 4 weeks, the implants of each tibia were removed and debridement was applied. Group 1 was designed as control group and no other treatment was applied other than debridement. Bone cement without any antibiotic was applied to Group 2, bone cement with teicoplanin was applied to Group 3 and bone cement with rifaximin was applied to Group 4. After 4 weeks from the second surgery, euthanasia was performed to the rats and the clinical, histopathological and microbiological results were compared.</p><p><strong>Results: </strong>There was no statistically significant difference between the groups in clinical scoring. A statistically significant difference was found between the histopathological scores of Group 1 and Group 2 and the histopathological scores of Groups 3 and 4; the histopathological scores of Group 1 and Group 2 were found to be higher than Group 3 and Group 4. When the pre-and post-treatment colony numbers were compared, although there was a statistically significant difference between Group 3 and Group 2, no statistically significant difference was found between Group 4 and Group 1 results.</p><p><strong>Conclusion: </strong>In spite of its wide spectrum, the local efficacy of rifaximin in the treatment of osteomyelitis could not be demonstrated. This study shows the ability to shed light on some future comprehensive studies with the inclusion of infection markers.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"505-513"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/67/NCI-9-505.PMC9677062.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of uncommon anatomic variation of the middle turbinate associated with contact point headache: Bilateral double middle turbinate. 中鼻甲少见解剖变异伴接触点头痛一例:双侧双中鼻甲。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2020.35651
Suha Ertugrul

By applying pressure to nasal mucosa, anatomic variations at nasal cavity and paranasal sinuses may cause headache without any sign of inflammatory diseases such as sinusitis or nasal polyp. This phenomenon is called as contact point headache (CPH) and observed as a result of concha variations, mostly due to concha bullosa. Accessory middle turbinate (AMT) is a very rare variation and occurred as a result of mediale and inferior folding of uncinate process. When this folding is severe, AMT may cause double middle concha appearance in nasal cavity. To the extent, we know, bilateral double middle turbinate variation has not been defined before. Hereby, we present a CPH phenomenon in a patient with bilateral double middle turbinate variation which is related to contact of AMT to real middle turbinate.

通过对鼻黏膜施加压力,鼻腔和鼻窦的解剖变化可能引起头痛,而没有鼻窦炎或鼻息肉等炎症性疾病的迹象。这种现象被称为接触点头痛(CPH),主要由耳甲大疱引起的耳甲变异引起。副中鼻甲(AMT)是一种非常罕见的变异,是钩状突内侧和下方折叠的结果。当这种折叠严重时,AMT可引起鼻腔双中耳甲外观。在某种程度上,我们知道,双侧双中鼻甲变异以前没有定义过。在此,我们报道一例双侧双中鼻甲变异患者的CPH现象,这与AMT与真实中鼻甲接触有关。
{"title":"A case of uncommon anatomic variation of the middle turbinate associated with contact point headache: Bilateral double middle turbinate.","authors":"Suha Ertugrul","doi":"10.14744/nci.2020.35651","DOIUrl":"https://doi.org/10.14744/nci.2020.35651","url":null,"abstract":"<p><p>By applying pressure to nasal mucosa, anatomic variations at nasal cavity and paranasal sinuses may cause headache without any sign of inflammatory diseases such as sinusitis or nasal polyp. This phenomenon is called as contact point headache (CPH) and observed as a result of concha variations, mostly due to concha bullosa. Accessory middle turbinate (AMT) is a very rare variation and occurred as a result of mediale and inferior folding of uncinate process. When this folding is severe, AMT may cause double middle concha appearance in nasal cavity. To the extent, we know, bilateral double middle turbinate variation has not been defined before. Hereby, we present a CPH phenomenon in a patient with bilateral double middle turbinate variation which is related to contact of AMT to real middle turbinate.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"537-539"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/7a/NCI-9-537.PMC9677061.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The successful management of type III coronary perforation. III型冠状动脉穿孔的成功治疗。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.43067
Mustafa Adem Tatlisu, Adem Atici, Aysu Oktay, Omer Faruk Baycan, Mustafa Caliskan

The coronary artery perforation during percutaneous coronary intervention is a nightmare for interventional cardiologists and is always hard to manage timely and properly. We present a 60-year-old male with periprocedural coronary perforation during ST-segment elevation myocardial infarction. A coronary balloon was inflated in the proximal left anterior descending (LAD) artery just after perforation and the 600 cc of hemorrhagic fluid was drained with the pericardial drainage set. The covered stent was deployed in the LAD and he was discharged on the 7th day. At an 18-month follow-up, he is on dual-antiplatelet therapy and the exercise stress test shows no ischemic changes.

经皮冠状动脉介入治疗中出现的冠状动脉穿孔一直是心脏科医师的噩梦,难以及时妥善处理。我们报告一位60岁男性患者在st段抬高型心肌梗死过程中发生冠状动脉穿孔。穿孔后,在左前降支近端充气冠状动脉球囊,用心包引流装置排出600毫升的出血性液体。覆盖支架放置在LAD中,患者于第7天出院。在18个月的随访中,他接受了双重抗血小板治疗,运动应激试验显示没有缺血性改变。
{"title":"The successful management of type III coronary perforation.","authors":"Mustafa Adem Tatlisu,&nbsp;Adem Atici,&nbsp;Aysu Oktay,&nbsp;Omer Faruk Baycan,&nbsp;Mustafa Caliskan","doi":"10.14744/nci.2021.43067","DOIUrl":"https://doi.org/10.14744/nci.2021.43067","url":null,"abstract":"<p><p>The coronary artery perforation during percutaneous coronary intervention is a nightmare for interventional cardiologists and is always hard to manage timely and properly. We present a 60-year-old male with periprocedural coronary perforation during ST-segment elevation myocardial infarction. A coronary balloon was inflated in the proximal left anterior descending (LAD) artery just after perforation and the 600 cc of hemorrhagic fluid was drained with the pericardial drainage set. The covered stent was deployed in the LAD and he was discharged on the 7<sup>th</sup> day. At an 18-month follow-up, he is on dual-antiplatelet therapy and the exercise stress test shows no ischemic changes.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"533-536"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d1/18/NCI-9-533.PMC9677057.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncooled microwave ablation of osteoid osteoma: New approaches to an old problem. 骨样骨瘤的非冷却微波消融:解决老问题的新方法。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.26675
Gulsah Yildirim, Hakki Muammer Karakas, Baris Yilmaz

Objective: This study aims to evaluate the technical and clinical success of uncooled microwave ablation (MWA) in the treatment of osteoid osteoma with two-dimensional fluoroscopy guidance in the operating room.

Methods: The clinical and imaging data of 9 patients were retrospectively evaluated. Mean patient age was 14.55 years. The mean size and volume of the lesions were 17.2 × 10.8 × 8.0 mm and the mean nidus size was 6.86±2.05 mm on computed tomography. MWA was performed with uncooled probe in operating room and in sterile conditions. Numerical pain score was recorded before the procedure, the day after, and at 1, 3 months after the procedure.

Results: Clinical and technical success was achieved in 100% of patients. The mean volume of MWA-induced necrosis was 20.8 × 12.8 × 10.7 mm, peripheral scar thickness was 3.5±0.75 mm, and none of the patients had nidus enhancement on first month follow-up magnetic resonance imaging. Fluoroscopic guidance was conducted under digital c-arm. Patients received four to 12 spot films (mean: 6.6 kVp, 2.66 mAs) over the lower extremity. Mean radiation exposure to the skin due to imaging was 0.02 mGy per patient per procedure. The dose area product-the total amount of radiation deliverable to the patient was 0.75±0.32 Gy.cm2.

Conclusion: This study demonstrated the effectiveness and the safety of the uncooled MWA in osteoid osteoma. The technique may effectively be used in operating room under c-arm fluoroscopy. Such hybrid approach may ensure sterility, anesthetic safety, and lower radiation dose to patients.

目的:本研究旨在评价二维透视引导下非冷却微波消融(MWA)在手术室治疗类骨瘤的技术和临床成功。方法:回顾性分析9例患者的临床及影像学资料。患者平均年龄14.55岁。ct显示病灶平均大小和体积为17.2 × 10.8 × 8.0 mm,病灶平均大小为6.86±2.05 mm。在手术室和无菌条件下使用非冷却探针进行MWA。术前、术后1、3个月分别记录疼痛数值评分。结果:100%患者临床及技术成功率。mwa诱导坏死的平均体积为20.8 × 12.8 × 10.7 mm,周围瘢痕厚度为3.5±0.75 mm,随访1个月磁共振成像无病灶强化。在数字c型臂下进行透视引导。患者在下肢接受4至12次点片(平均:6.6 kVp, 2.66 ma)。每位患者每次手术的平均皮肤辐射暴露量为0.02 mGy。剂量面积积-患者可接受的总辐射量为0.75±0.32 Gy.cm2。结论:本研究证明了非冷却MWA治疗类骨瘤的有效性和安全性。该技术可在手术室c臂透视下有效应用。这种混合方法可以确保无菌性、麻醉安全性和对患者的低辐射剂量。
{"title":"Uncooled microwave ablation of osteoid osteoma: New approaches to an old problem.","authors":"Gulsah Yildirim,&nbsp;Hakki Muammer Karakas,&nbsp;Baris Yilmaz","doi":"10.14744/nci.2021.26675","DOIUrl":"https://doi.org/10.14744/nci.2021.26675","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the technical and clinical success of uncooled microwave ablation (MWA) in the treatment of osteoid osteoma with two-dimensional fluoroscopy guidance in the operating room.</p><p><strong>Methods: </strong>The clinical and imaging data of 9 patients were retrospectively evaluated. Mean patient age was 14.55 years. The mean size and volume of the lesions were 17.2 × 10.8 × 8.0 mm and the mean nidus size was 6.86±2.05 mm on computed tomography. MWA was performed with uncooled probe in operating room and in sterile conditions. Numerical pain score was recorded before the procedure, the day after, and at 1, 3 months after the procedure.</p><p><strong>Results: </strong>Clinical and technical success was achieved in 100% of patients. The mean volume of MWA-induced necrosis was 20.8 × 12.8 × 10.7 mm, peripheral scar thickness was 3.5±0.75 mm, and none of the patients had nidus enhancement on first month follow-up magnetic resonance imaging. Fluoroscopic guidance was conducted under digital c-arm. Patients received four to 12 spot films (mean: 6.6 kVp, 2.66 mAs) over the lower extremity. Mean radiation exposure to the skin due to imaging was 0.02 mGy per patient per procedure. The dose area product-the total amount of radiation deliverable to the patient was 0.75±0.32 Gy.cm<sup>2</sup>.</p><p><strong>Conclusion: </strong>This study demonstrated the effectiveness and the safety of the uncooled MWA in osteoid osteoma. The technique may effectively be used in operating room under c-arm fluoroscopy. Such hybrid approach may ensure sterility, anesthetic safety, and lower radiation dose to patients.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"524-529"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/6d/NCI-9-524.PMC9677055.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
EUS-FNA and ROSE in solid lesions of the pancreas; have the same diagnostic efficacy compared to pancreatic sites? 胰腺实性病变EUS-FNA和ROSE;与胰腺部位相比有相同的诊断效果吗?
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.79119
Cagatay Ak, Suleyman Sayar, Ebru Tarikci Kilic, Resul Kahraman, Oguzhan Ozturk, Itir Ebru Zemheri, Kamil Ozdil

Objective: Various techniques, needle types, and additional methods such as on-site pathological evaluation (ROSE) are used to increase the sensitivity of endoscopic ultrasound-fine needle aspiration (EUS-FNA), which is used in the diagnosis of pancreatic solid lesions. In this study, diagnosticity of the lesions according to the regions of the pancreas with EUS-FNA and ROSE performed with the slow pull technique using a 22 G needle will be evaluated.

Methods: A total of 82 patients who underwent EUS-FNA between January 2, 2015, and March 14, 2020, were included in the study. General and clinical information of the patients were recorded retrospectively. The patients were diagnosed according to The Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology Classification. If the diagnosis could not be made with EUS-FNA and ROSE, the diagnosis was made with alternative methods of surgery or percutaneous biopsy. Patients diagnosed as benign with EUS-FNA and ROSE were followed for at least 1 year and were accepted as benign.

Results: The mean age of the patients was 63.2±10.5 years and 54 (69.6%) of them were male. The mean lesion size was 36.8 mm and the number of needle passes was 2.87. The overall sensitivity was 82.9% and the specificity was 100%. The sensitivity of EUS-FNA and ROSE in solid lesions in the head and body of the pancreas was higher than in lesions in the tail region (p=0.024).

Conclusion: EUS-FNA and ROSE are an effective method in the diagnosis of pancreatic solid lesions. The use of a 22 G needle may be more diagnostic in the head and body of the pancreas than in the tail region.

目的:采用多种技术、针型及现场病理评价(ROSE)等附加方法,提高内镜下超声细针穿刺(EUS-FNA)在胰腺实性病变诊断中的敏感性。在本研究中,将根据胰腺区域使用EUS-FNA和ROSE进行诊断,并使用22 G针慢拉技术进行评估。方法:研究纳入2015年1月2日至2020年3月14日期间接受EUS-FNA治疗的82例患者。回顾性记录患者的一般资料和临床资料。根据Papanicolaou细胞病理学学会胰胆管细胞学分类报告系统进行诊断。如果EUS-FNA和ROSE无法诊断,则采用手术或经皮活检的替代方法进行诊断。经EUS-FNA和ROSE诊断为良性的患者随访至少1年,并接受为良性。结果:患者平均年龄63.2±10.5岁,男性54例(69.6%)。平均病灶大小36.8 mm,针经次数2.87次。总敏感性为82.9%,特异性为100%。EUS-FNA和ROSE在胰腺头部和身体实体病变中的敏感性高于尾部病变(p=0.024)。结论:EUS-FNA和ROSE是诊断胰腺实性病变的有效方法。在胰腺的头部和身体部位使用22g针可能比在尾部区域更有诊断价值。
{"title":"EUS-FNA and ROSE in solid lesions of the pancreas; have the same diagnostic efficacy compared to pancreatic sites?","authors":"Cagatay Ak,&nbsp;Suleyman Sayar,&nbsp;Ebru Tarikci Kilic,&nbsp;Resul Kahraman,&nbsp;Oguzhan Ozturk,&nbsp;Itir Ebru Zemheri,&nbsp;Kamil Ozdil","doi":"10.14744/nci.2022.79119","DOIUrl":"https://doi.org/10.14744/nci.2022.79119","url":null,"abstract":"<p><strong>Objective: </strong>Various techniques, needle types, and additional methods such as on-site pathological evaluation (ROSE) are used to increase the sensitivity of endoscopic ultrasound-fine needle aspiration (EUS-FNA), which is used in the diagnosis of pancreatic solid lesions. In this study, diagnosticity of the lesions according to the regions of the pancreas with EUS-FNA and ROSE performed with the slow pull technique using a 22 G needle will be evaluated.</p><p><strong>Methods: </strong>A total of 82 patients who underwent EUS-FNA between January 2, 2015, and March 14, 2020, were included in the study. General and clinical information of the patients were recorded retrospectively. The patients were diagnosed according to The Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology Classification. If the diagnosis could not be made with EUS-FNA and ROSE, the diagnosis was made with alternative methods of surgery or percutaneous biopsy. Patients diagnosed as benign with EUS-FNA and ROSE were followed for at least 1 year and were accepted as benign.</p><p><strong>Results: </strong>The mean age of the patients was 63.2±10.5 years and 54 (69.6%) of them were male. The mean lesion size was 36.8 mm and the number of needle passes was 2.87. The overall sensitivity was 82.9% and the specificity was 100%. The sensitivity of EUS-FNA and ROSE in solid lesions in the head and body of the pancreas was higher than in lesions in the tail region (p=0.024).</p><p><strong>Conclusion: </strong>EUS-FNA and ROSE are an effective method in the diagnosis of pancreatic solid lesions. The use of a 22 G needle may be more diagnostic in the head and body of the pancreas than in the tail region.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"464-469"},"PeriodicalIF":1.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/17/NCI-9-464.PMC9677044.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Distribution of respiratory viruses: Evaluation of multiplex PCR results of 3074 patients. 呼吸道病毒分布:3074例患者多重PCR结果评价
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-26 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.28034
Ulku Oral Zeytinli, Ayca Ozer Durmuslu, Ferhat Gurkan Aslan, Solen Daldaban Dincer, Pinar Eker, Sebahat Aksaray

Objective: Early and accurate diagnosis of acute respiratory infections is important because these diseases negatively affect public health and can lead to loss of workforce and an increase in health expenditures. In this study, we aimed to determine the respiration panel multiplex polymerase chain reaction (PCR) test results and seasonal distribution in our region.

Methods: Three thousand and seventy-four patients samples multiplex PCR (Anatolia, Bosphore® Respiratory Pathogens Panel Kit v1) test results, which were sent to our laboratory, from 13 hospitals in our region between January 2018 and December 2018, were evaluated retrospectively.

Results: A total of 3074 patients samples, 1465 (48%) were positive and 1609 (52%) were negative test results. The most common factors were rhinovirus 30.2%, influenza A 23.1%, and respiratory syncytial virus (RSV) A/B 19.1%, respectively. When the distribution of these three most common viruses by months is examined, the most frequent months were determined as June for rhinovirus, November for influenza A, and February for RSV A/B. In the period between October and February, there was a significant increase in the positivity level of viral factors.

Conclusion: The use of molecular methods in the diagnosis of respiratory infections will prevent unnecessary use of antibiotics and ensure correct and rapid treatment.

目的:早期和准确诊断急性呼吸道感染很重要,因为这些疾病对公共卫生产生负面影响,并可能导致劳动力损失和卫生支出增加。在本研究中,我们旨在确定呼吸面板多重聚合酶链反应(PCR)检测结果和我们地区的季节分布。方法:回顾性分析2018年1月至2018年12月本地区13家医院送至本实验室的374例患者多重PCR (Anatolia, Bosphore®Respiratory Pathogens Panel Kit v1)检测结果。结果:共3074例患者标本,阳性1465例(48%),阴性1609例(52%)。最常见的感染因素分别是鼻病毒(30.2%)、甲型流感(23.1%)和呼吸道合胞病毒(RSV) A/B(19.1%)。当按月份检查这三种最常见病毒的分布时,确定最常见的月份为鼻病毒的6月,流感A的11月和RSV A/B的2月。在10月至2月期间,病毒因子的阳性水平显著增加。结论:应用分子方法诊断呼吸道感染可避免抗生素的不必要使用,保证正确、快速的治疗。
{"title":"Distribution of respiratory viruses: Evaluation of multiplex PCR results of 3074 patients.","authors":"Ulku Oral Zeytinli,&nbsp;Ayca Ozer Durmuslu,&nbsp;Ferhat Gurkan Aslan,&nbsp;Solen Daldaban Dincer,&nbsp;Pinar Eker,&nbsp;Sebahat Aksaray","doi":"10.14744/nci.2021.28034","DOIUrl":"https://doi.org/10.14744/nci.2021.28034","url":null,"abstract":"<p><strong>Objective: </strong>Early and accurate diagnosis of acute respiratory infections is important because these diseases negatively affect public health and can lead to loss of workforce and an increase in health expenditures. In this study, we aimed to determine the respiration panel multiplex polymerase chain reaction (PCR) test results and seasonal distribution in our region.</p><p><strong>Methods: </strong>Three thousand and seventy-four patients samples multiplex PCR (Anatolia, Bosphore<sup>®</sup> Respiratory Pathogens Panel Kit v1) test results, which were sent to our laboratory, from 13 hospitals in our region between January 2018 and December 2018, were evaluated retrospectively.</p><p><strong>Results: </strong>A total of 3074 patients samples, 1465 (48%) were positive and 1609 (52%) were negative test results. The most common factors were rhinovirus 30.2%, influenza A 23.1%, and respiratory syncytial virus (RSV) A/B 19.1%, respectively. When the distribution of these three most common viruses by months is examined, the most frequent months were determined as June for rhinovirus, November for influenza A, and February for RSV A/B. In the period between October and February, there was a significant increase in the positivity level of viral factors.</p><p><strong>Conclusion: </strong>The use of molecular methods in the diagnosis of respiratory infections will prevent unnecessary use of antibiotics and ensure correct and rapid treatment.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"501-504"},"PeriodicalIF":1.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/3d/NCI-9-501.PMC9677051.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Growth hormone level in COVID-19 patients. COVID-19患者的生长激素水平
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-26 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.90094
Emine Kartal Baykan, Ahmed Ramiz Baykan, Mustafa Utlu, Emre Deve, Faruk Yildiz, Canan Birdal, Yilmaz Ozdemir, Mehtap Hulya Aslan, Konca Altinkaynak

Objective: Coronavirus disease-2019 (COVID-19) disease can cause asymptomatic and mild flu-like symptoms as well as severe symptoms ranging from respiratory failure and death. Growth hormone (GH) is produced in the anterior pituitary and plays an important role in the immune system. COVID-19 is severe in the elderly, men, obese, diabetics, and people with immune deficiency. The probability of GH deficiency is high in these patient groups. In this study, we aimed to investigate the relationship between the severity of COVID-19 infection and GH level.

Methods: A total of 456 patients, between 45 and 80-years-old, who were hospitalized with the diagnosis of COVID-19 disease were evaluated in the study. Our study was a retrospective study. Demographic data of the patients, GH, insulin-like growth factor-I (IGF-1), and biochemical parameters and thorax tomography results were evaluated. Patients with chronic diseases that would affect GH levels and those in need of intensive care were excluded from the study.

Results: 456 patients were included in the study, 168 female, 288 male, mean age 67.57±12.60 years. Patients were divided into two groups according to thorax tomography findings, patients with lung involvement in Group-1:352 (77%) and those without pulmonary involvement in Group-2:104 (23%). While the GH of Group-1 was 0.125 ng/ml, the GH of Group-2 was 0.238 ng/ml, the difference between them was statistically significant (p=0.000). IGF-1 in Group-1 was: 55.05 ng/ml, while IGF-1 in Group-2 was: 104.08 ng/ml, the difference between them was statistically significant (p=0.000). In multivariate regression analysis, low IGF-1 (p=<0,01, OR:1,06 [1028-1093]) level was found to be significantly effective in lung involvement in COVID-19 disease.

Conclusion: In our study, we found GH and IGF-1 deficiency in COVID-19 cases with lung involvement, regardless of age and gender. We can say that COVID-19 infection progresses worse in GH and IGF-1 deficiency.

目的:冠状病毒病-2019 (COVID-19)可引起无症状和轻度流感样症状,也可引起呼吸衰竭和死亡等严重症状。生长激素(GH)产生于垂体前叶,在免疫系统中起重要作用。COVID-19在老年人、男性、肥胖、糖尿病患者和免疫缺陷人群中严重。在这些患者群体中,生长激素缺乏的可能性很高。在本研究中,我们旨在探讨COVID-19感染严重程度与GH水平的关系。方法:对456例45 ~ 80岁的新冠肺炎住院患者进行评估。我们的研究是回顾性研究。评估患者的人口统计学数据、GH、胰岛素样生长因子-1 (IGF-1)、生化参数和胸部断层扫描结果。患有影响生长激素水平的慢性疾病的患者和需要重症监护的患者被排除在研究之外。结果:纳入研究的患者456例,女性168例,男性288例,平均年龄67.57±12.60岁。根据胸部断层扫描结果将患者分为两组,有肺受累组1:32 52(77%)和无肺受累组2:104(23%)。1组GH为0.125 ng/ml, 2组GH为0.238 ng/ml,差异有统计学意义(p=0.000)。1组IGF-1为:55.05 ng/ml, 2组IGF-1为:104.08 ng/ml,差异有统计学意义(p=0.000)。结论:在我们的研究中,我们发现生长激素和IGF-1缺乏在肺部受累的COVID-19病例中,无论年龄和性别。我们可以说,GH和IGF-1缺乏症患者的COVID-19感染进展更糟。
{"title":"Growth hormone level in COVID-19 patients.","authors":"Emine Kartal Baykan,&nbsp;Ahmed Ramiz Baykan,&nbsp;Mustafa Utlu,&nbsp;Emre Deve,&nbsp;Faruk Yildiz,&nbsp;Canan Birdal,&nbsp;Yilmaz Ozdemir,&nbsp;Mehtap Hulya Aslan,&nbsp;Konca Altinkaynak","doi":"10.14744/nci.2021.90094","DOIUrl":"https://doi.org/10.14744/nci.2021.90094","url":null,"abstract":"<p><strong>Objective: </strong>Coronavirus disease-2019 (COVID-19) disease can cause asymptomatic and mild flu-like symptoms as well as severe symptoms ranging from respiratory failure and death. Growth hormone (GH) is produced in the anterior pituitary and plays an important role in the immune system. COVID-19 is severe in the elderly, men, obese, diabetics, and people with immune deficiency. The probability of GH deficiency is high in these patient groups. In this study, we aimed to investigate the relationship between the severity of COVID-19 infection and GH level.</p><p><strong>Methods: </strong>A total of 456 patients, between 45 and 80-years-old, who were hospitalized with the diagnosis of COVID-19 disease were evaluated in the study. Our study was a retrospective study. Demographic data of the patients, GH, insulin-like growth factor-I (IGF-1), and biochemical parameters and thorax tomography results were evaluated. Patients with chronic diseases that would affect GH levels and those in need of intensive care were excluded from the study.</p><p><strong>Results: </strong>456 patients were included in the study, 168 female, 288 male, mean age 67.57±12.60 years. Patients were divided into two groups according to thorax tomography findings, patients with lung involvement in Group-1:352 (77%) and those without pulmonary involvement in Group-2:104 (23%). While the GH of Group-1 was 0.125 ng/ml, the GH of Group-2 was 0.238 ng/ml, the difference between them was statistically significant (p=0.000). IGF-1 in Group-1 was: 55.05 ng/ml, while IGF-1 in Group-2 was: 104.08 ng/ml, the difference between them was statistically significant (p=0.000). In multivariate regression analysis, low IGF-1 (p=<0,01, OR:1,06 [1028-1093]) level was found to be significantly effective in lung involvement in COVID-19 disease.</p><p><strong>Conclusion: </strong>In our study, we found GH and IGF-1 deficiency in COVID-19 cases with lung involvement, regardless of age and gender. We can say that COVID-19 infection progresses worse in GH and IGF-1 deficiency.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"470-475"},"PeriodicalIF":1.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/92/NCI-9-470.PMC9677050.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40723033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. 斑秃患者的临床特征和合并症的回顾性评价。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-24 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2022.78790
Sule Goksin

Objective: The aim of the study was to determine the clinical profile of the patients with alopecia areata (AA) and whether or not any differences between the AA patients with and without comorbidity.

Methods: A total of 218 patients diagnosed with AA between January 1, 2016, and August 31, 2020, in our outpatient clinic were analyzed retrospectively.

Results: The mean age was 27.8±12.3. 61.5% of the patients were male (M/F=1.59). There were AA in 96.3%, alopecia universalis in 3.2%, and alopecia totalis in 0.5% of the patients. Most of them showed unifocal involvement (85.8%) and multifocal involvement to a smaller extent (10.5%). Number of patches was 1 in 75.2%, 2 in 16.7% and 3 or more in 8.1% of AA patients. Average disease duration was 18.1 months. Comorbid diseases were accompanying to 51.8% of the patients. Dermatological diseases were among the most common accompanying diseases (17.9%). However, hypothyroidism (12.8%) was the most frequent comorbid disease. There were thyroidal diseases in 15.1%, allergic disorders in 7.7%, psychiatric disorders in 7.3%, anemia in 5.9%, rheumatic diseases in 2.2%, other endocrine diseases in 1.8%, malignancy in 1.3%, and morbid obesity in 1.3% of the patients. Down syndrome accompanied in 0.9%. Vitamin-D deficiency (38.9%), low ferritin (13.8%), and B12 deficiency (9.6%) were also detected. Female gender (46.9 to 29.5%, p=0.008), extensive disease (p=0.085), Vitamin B12 deficiency (13.3 to 5.7%, p=0.059), and low ferritin level (20.4 to 6.7%, p=0.003) were observed more in patients with comorbidity than those without one.

Conclusion: AA accompanies various systemic, autoimmune, and psychiatric diseases. Dermatologists need to recognize potential comorbid diseases, evaluate and manage these patients with a multidisciplinary approach to achieve a better outcome.

目的:探讨斑秃(AA)患者的临床特征及有无合并症的AA患者之间是否存在差异。方法:回顾性分析2016年1月1日至2020年8月31日在我院门诊诊断为AA的218例患者。结果:平均年龄27.8±12.3岁。男性占61.5% (M/F=1.59)。秃发占96.3%,秃发占3.2%,秃发占0.5%。多数为单焦受累(85.8%),少部分为多焦受累(10.5%)。贴片数量75.2%为1个,16.7%为2个,8.1%为3个及以上。平均病程18.1个月。51.8%的患者伴有合并症。皮肤病是最常见的伴随疾病(17.9%)。然而,甲状腺功能减退(12.8%)是最常见的合并症。其中甲状腺疾病占15.1%,过敏性疾病占7.7%,精神疾病占7.3%,贫血占5.9%,风湿病占2.2%,其他内分泌疾病占1.8%,恶性肿瘤占1.3%,病态肥胖占1.3%。伴有唐氏综合症的占0.9%。维生素d缺乏(38.9%)、低铁蛋白(13.8%)和B12缺乏(9.6%)也被检测到。女性(46.9 ~ 29.5%,p=0.008)、疾病广泛(p=0.085)、维生素B12缺乏(13.3 ~ 5.7%,p=0.059)、铁蛋白水平低(20.4 ~ 6.7%,p=0.003)合并症患者多于无合并症患者。结论:AA伴发多种全身、自身免疫和精神疾病。皮肤科医生需要认识到潜在的合并症疾病,评估和管理这些患者与多学科的方法,以达到更好的结果。
{"title":"Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata.","authors":"Sule Goksin","doi":"10.14744/nci.2022.78790","DOIUrl":"https://doi.org/10.14744/nci.2022.78790","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to determine the clinical profile of the patients with alopecia areata (AA) and whether or not any differences between the AA patients with and without comorbidity.</p><p><strong>Methods: </strong>A total of 218 patients diagnosed with AA between January 1, 2016, and August 31, 2020, in our outpatient clinic were analyzed retrospectively.</p><p><strong>Results: </strong>The mean age was 27.8±12.3. 61.5% of the patients were male (M/F=1.59). There were AA in 96.3%, alopecia universalis in 3.2%, and alopecia totalis in 0.5% of the patients. Most of them showed unifocal involvement (85.8%) and multifocal involvement to a smaller extent (10.5%). Number of patches was 1 in 75.2%, 2 in 16.7% and 3 or more in 8.1% of AA patients. Average disease duration was 18.1 months. Comorbid diseases were accompanying to 51.8% of the patients. Dermatological diseases were among the most common accompanying diseases (17.9%). However, hypothyroidism (12.8%) was the most frequent comorbid disease. There were thyroidal diseases in 15.1%, allergic disorders in 7.7%, psychiatric disorders in 7.3%, anemia in 5.9%, rheumatic diseases in 2.2%, other endocrine diseases in 1.8%, malignancy in 1.3%, and morbid obesity in 1.3% of the patients. Down syndrome accompanied in 0.9%. Vitamin-D deficiency (38.9%), low ferritin (13.8%), and B12 deficiency (9.6%) were also detected. Female gender (46.9 to 29.5%, p=0.008), extensive disease (p=0.085), Vitamin B12 deficiency (13.3 to 5.7%, p=0.059), and low ferritin level (20.4 to 6.7%, p=0.003) were observed more in patients with comorbidity than those without one.</p><p><strong>Conclusion: </strong>AA accompanies various systemic, autoimmune, and psychiatric diseases. Dermatologists need to recognize potential comorbid diseases, evaluate and manage these patients with a multidisciplinary approach to achieve a better outcome.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"451-458"},"PeriodicalIF":1.0,"publicationDate":"2022-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fe/02/NCI-9-451.PMC9677058.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40711843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Extended length of stay after elective ascending aortic surgery and associated risk factors. 择期升主动脉手术后住院时间延长及相关危险因素。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-24 eCollection Date: 2022-01-01 DOI: 10.14744/nci.2021.27037
Levent Ceylan, Abdulkerim Ozhan, Murat Bastopcu, Sevinc Bayer Erdogan

Objective: Surgery on the ascending aorta incurs greater risk than other cardiac procedures. The primary aim of this study is to identify pre-operative and operative risk factors that play a role in extended length of stay (LOS) after elective surgery for ascending aortic aneurysms. The secondary aim is to determine post-operative outcomes associated with extended LOS.

Methods: Patients who underwent elective surgery aged >18 between January 2018 and December 2019 for ascending aortic aneurysm with or without concomitant interventions in a single heart surgery center were retrospectively identified. Patients with days of hospital stay longer than the median length made up the extended stay group. The extended stay group was compared against the rest of the patients for demographics and operative parameters, as well as post-operative outcomes.

Results: Patients with extended LOS were older (60.0±12.2 vs. 54.0±14.2, p=0.001) with more frequent coronary artery disease (CAD) (47.2% vs. 23.7%, p<0.001) and chronic obstructive pulmonary disease (COPD) (25.0% vs. 11.9% p=0.013). More patients in the extended LOS group required HCA for distal aortic anastomosis (43.5% vs. 17.5%, p<0.001) and cardiopulmonary bypass (CPB) durations were longer (283.1±83.9 vs. 225.3±84.2 min, p<0.001). Multivariate analysis revealed age, CAD, COPD, HCA, and CPB time as risk factors for extended LOS. Extended LOS patients had longer mechanical ventilation times (23.0±21.3 vs. 13.6±5.3 h, p<0.001), more frequently had acute renal failure (24.2% vs. 6.7%, p<0.001), reoperation for bleeding (20.7% vs. 6.7%, p=0.003), and stroke (14.3% vs. 4.3%, p=0.011).

Conclusion: In elective surgery for ascending aortic aneurysms older age, history of COPD and CAD, longer CPB times, and HCA during surgery are associated with extended LOS. Further studies are needed to investigate the association of prolonged hospital stay with long-term outcomes, as well as the impact of operation type on hospital stay.

目的:升主动脉手术比其他心脏手术风险更大。本研究的主要目的是确定升主动脉瘤择期手术后延长住院时间(LOS)的术前和术中危险因素。第二个目的是确定与延长的LOS相关的术后结果。方法:回顾性分析2018年1月至2019年12月在单个心脏手术中心接受升主动脉瘤择期手术的年龄>18岁的患者,无论是否伴有干预措施。住院天数超过中位数的患者组成了延长住院组。将延长住院组与其他患者进行人口统计学和手术参数以及术后结果的比较。结果:延长的LOS患者年龄较大(60.0±12.2比54.0±14.2,p=0.001),冠状动脉疾病(CAD)发生率更高(47.2%比23.7%)。结论:在升主动脉瘤择期手术中,年龄较大、有COPD和CAD病史、CPB时间较长、术中HCA与延长的LOS相关。需要进一步研究延长住院时间与长期预后的关系,以及手术类型对住院时间的影响。
{"title":"Extended length of stay after elective ascending aortic surgery and associated risk factors.","authors":"Levent Ceylan,&nbsp;Abdulkerim Ozhan,&nbsp;Murat Bastopcu,&nbsp;Sevinc Bayer Erdogan","doi":"10.14744/nci.2021.27037","DOIUrl":"https://doi.org/10.14744/nci.2021.27037","url":null,"abstract":"<p><strong>Objective: </strong>Surgery on the ascending aorta incurs greater risk than other cardiac procedures. The primary aim of this study is to identify pre-operative and operative risk factors that play a role in extended length of stay (LOS) after elective surgery for ascending aortic aneurysms. The secondary aim is to determine post-operative outcomes associated with extended LOS.</p><p><strong>Methods: </strong>Patients who underwent elective surgery aged >18 between January 2018 and December 2019 for ascending aortic aneurysm with or without concomitant interventions in a single heart surgery center were retrospectively identified. Patients with days of hospital stay longer than the median length made up the extended stay group. The extended stay group was compared against the rest of the patients for demographics and operative parameters, as well as post-operative outcomes.</p><p><strong>Results: </strong>Patients with extended LOS were older (60.0±12.2 vs. 54.0±14.2, p=0.001) with more frequent coronary artery disease (CAD) (47.2% vs. 23.7%, p<0.001) and chronic obstructive pulmonary disease (COPD) (25.0% vs. 11.9% p=0.013). More patients in the extended LOS group required HCA for distal aortic anastomosis (43.5% vs. 17.5%, p<0.001) and cardiopulmonary bypass (CPB) durations were longer (283.1±83.9 vs. 225.3±84.2 min, p<0.001). Multivariate analysis revealed age, CAD, COPD, HCA, and CPB time as risk factors for extended LOS. Extended LOS patients had longer mechanical ventilation times (23.0±21.3 vs. 13.6±5.3 h, p<0.001), more frequently had acute renal failure (24.2% vs. 6.7%, p<0.001), reoperation for bleeding (20.7% vs. 6.7%, p=0.003), and stroke (14.3% vs. 4.3%, p=0.011).</p><p><strong>Conclusion: </strong>In elective surgery for ascending aortic aneurysms older age, history of COPD and CAD, longer CPB times, and HCA during surgery are associated with extended LOS. Further studies are needed to investigate the association of prolonged hospital stay with long-term outcomes, as well as the impact of operation type on hospital stay.</p>","PeriodicalId":19164,"journal":{"name":"Northern Clinics of Istanbul","volume":"9 5","pages":"445-450"},"PeriodicalIF":1.0,"publicationDate":"2022-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/52/NCI-9-445.PMC9677049.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40723034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Northern Clinics of Istanbul
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1